Recent years have witnessed significant shifts in the landscape of merger and acquisition (M&A) activity, particularly within the health care systems. These changes have prompted the U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC) to propose updates to their merger guidelines. While the changes are expected to bring increased clarity and uniformity to M&A legal practices, they also promise to alter the landscape of antitrust scrutiny within the health care sector.
Originally reported by Stevens & Lee on JD Supra, the proposed updates by the FTC and DOJ are intended to guide the Agencies’ review of mergers across all sectors to ensure compliance with federal antitrust laws. However, the impact of these changes on health care systems could be particularly significant, given the sector’s rampant M&A activity and the federal government’s increased focus on antitrust compliance within the industry.
The proposed changes are a consequence of increasing globalization and the ever-complex landscape of vertical and horizontal integrations. Over the years, these factors have rendered the original guidelines increasingly outdated and inadequate. The revised guidelines are designed to bring added efficiency, improved predictive accuracy, and increased transparency to all M&A evaluations, letting the reviewing agencies stay ahead of industry trends.
While the FTC and DOJ embark on the challenging task of revising the guidelines, there remains a degree of uncertainty about the changes, especially regarding how they will impact the review of future health care merger and acquisitions. Consequently, it is becoming increasingly important for health care systems and their legal advisors to stay abreast of these developments.
As these changes are introduced and take effect, companies — especially within the health care sector — will need to reassess their M&A strategies and consider the implications of merging under a revamped regulatory regime. Legal professionals tracking these changes should continue monitoring FTC and DOJ announcements to ensure timely adjustments to their strategies and to secure regulatory compliance and success in the evolving M&A market.